Archer Investment Corp Apellis Pharmaceuticals, Inc. Transaction History
Archer Investment Corp
- $375 Billion
- Q4 2024
A detailed history of Archer Investment Corp transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Archer Investment Corp holds 500 shares of APLS stock, worth $13,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$13,450
Previous $14.4 Million
10.64%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$329 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$320 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$317 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$270 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$259 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.96B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...